Pulmonary Surfactants for Acute and Chronic Lung Diseases (Part II)

Part 2 of the review considers the problem of surfactant therapy for acute respiratory distress syndrome (ARDS) in adults and young and old children. It gives information on the results of surfactant therapy and prevention of ARDS in patients with severe concurrent trauma, inhalation injuries, compl...

Full description

Bibliographic Details
Main Author: O. A. Rozenberg
Format: Article
Language:Russian
Published: Russian Academy of Medical Sciences 2014-10-01
Series:Obŝaâ Reanimatologiâ
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/1423
Description
Summary:Part 2 of the review considers the problem of surfactant therapy for acute respiratory distress syndrome (ARDS) in adults and young and old children. It gives information on the results of surfactant therapy and prevention of ARDS in patients with severe concurrent trauma, inhalation injuries, complications due to complex expanded chest surgery, or severe pneumonias, including bilateral pneumonia in the presence of A/H1N1 influenza. There are data on the use of a surfactant in obstetric care and prevention of primary graft dysfunction during lung transplantation. The results of longterm use of surfactant therapy in Russia, suggesting that death rates from ARDS may be substantially reduced (to 20%) are discussed. Examples of surfactant therapy for other noncritical lung diseases, such as permanent athelectasis, chronic obstructive pulmonary diseases, and asthma, as well tuberculosis, are also considered.
ISSN:1813-9779
2411-7110